Cargando…

Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection

Pulmonary exacerbations in adults with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa (Psae) infection are usually treated with dual intravenous antibiotics for 14 days, despite the lack of evidence for best practice. Intravenous antibiotics are commonly associated with various systemic adv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mann, Nina, Murray, Shirley, Hoo, Zhe Hui, Curley, Rachael, Wildman, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832909/ https://www.ncbi.nlm.nih.gov/pubmed/29560254 http://dx.doi.org/10.12688/f1000research.13298.2

Ejemplares similares

Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study
por: Gao, Jie, et al.
Publicado: (2019)

Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CF
por: Hoo, Zhe Hui, et al.
Publicado: (2017)

An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosis
por: Hoo, Zhe H, et al.
Publicado: (2017)

Understanding Pseudomonas status among adults with cystic fibrosis: a real-world comparison of the Leeds criteria against clinicians’ decision
por: Hoo, Zhe Hui, et al.
Publicado: (2018)

Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate “normative adherence”
por: Hoo, Zhe Hui, et al.
Publicado: (2016)

Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub
por: Arden, M. A., et al.
Publicado: (2021)

Promoting adherence to nebulized therapy in cystic fibrosis: poster development and a qualitative exploration of adherence
por: Jones, Stephen, et al.
Publicado: (2015)

Using different methods to process forced expiratory volume in one second (FEV (1)) data can impact on the interpretation of FEV (1) as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review
por: Hoo, Zhe Hui, et al.
Publicado: (2018)

The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV(1) in the UK only collected when subjects are well?
por: Hoo, Zhe Hui, et al.
Publicado: (2018)

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations
por: Bell, Jane, et al.
Publicado: (2020)

Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
por: Lumley, Elizabeth, et al.
Publicado: (2022)

Prospectively predicting Pseudomonas aeruginosa infection/s using routine data from the UK cystic fibrosis register
por: Totton, Nikki, et al.
Publicado: (2021)

Investigating the Temporal Relationships between Symptoms and Nebuliser Adherence in People with Cystic Fibrosis: A Series of N-of-1 Observations
por: Martin, Rosie, et al.
Publicado: (2020)

Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
por: Forde, Éanna, et al.
Publicado: (2019)

Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
por: Singh, Jagdev, et al.
Publicado: (2023)

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis
por: Schwarz, Carsten, et al.
Publicado: (2022)

A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis
por: Hoo, Zhe Hui, et al.
Publicado: (2019)

Molecular Epidemiology of Chronic Pseudomonas aeruginosa Airway Infections in Cystic Fibrosis
por: Cramer, Nina, et al.
Publicado: (2012)

Regarding the articles on home spirometry
por: Curley, Rachael, et al.
Publicado: (2022)

P121 The effect of training about nebuliser cleaning and disinfection on the knowledge levels and practises of the caregivers of patients with cystic fibrosis
por: Cenk, M., et al.
Publicado: (2021)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
por: Clancy, J P, et al.
Publicado: (2013)

Metabotypes of Pseudomonas aeruginosa Correlate with Antibiotic Resistance, Virulence and Clinical Outcome in Cystic Fibrosis Chronic Infections
por: Moyne, Oriane, et al.
Publicado: (2021)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
por: Li, Danni, et al.
Publicado: (2023)

Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data
por: Granger, Emily, et al.
Publicado: (2023)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis
por: Tai, Anna S., et al.
Publicado: (2017)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
por: AbdulWahab, Atqah, et al.
Publicado: (2017)

Association between clinical antibiotic resistance and susceptibility of Pseudomonas in the cystic fibrosis lung
por: Jansen, Gunther, et al.
Publicado: (2016)

P141 Has the COVID-19 pandemic affected medication adherence to inhaled nebulised therapy for patients at a large adult cystic fibrosis centre?
por: Iqbal, N., et al.
Publicado: (2021)

Modelling Successful Self-Management in Adults With Cystic Fibrosis: Vicarious Self-Efficacy From Videos of ‘People Like Me’
por: Hutchings, Marlene, et al.
Publicado: (2022)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Double Nebulisation for Airway Anaesthesia
por: Chugh, Vanya, et al.
Publicado: (2020)

Patient attitudes to nebulised antibiotics in the treatment of bronchiectasis: a mixed-methods study
por: Davison, John, et al.
Publicado: (2023)

The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2018)

Mucoidy, Quorum Sensing, Mismatch Repair and Antibiotic Resistance in Pseudomonas aeruginosa from Cystic Fibrosis Chronic Airways Infections
por: Feliziani, Sofía, et al.
Publicado: (2010)

Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection
por: López-Causapé, Carla, et al.
Publicado: (2013)

Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2019)

Is it Worth Adding Systemic Antibiotics to Inhalational Tobramycin Therapy to Treat Pseudomonas Infections in Cystic Fibrosis?
por: Karki, Kumar, et al.
Publicado: (2021)

Pseudomonas aeruginosa is oxygen-deprived during infection in cystic fibrosis lungs, reducing the effectiveness of antibiotics
por: Martin, Lois W, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lurd5h4nqd7raprac1ooe4fb2a